DOLPHIN Study

About The Study

Researchers at Brigham and Women’s Hospital are conducting a clinical research study for adults diagnosed with Primary Sclerosing Cholangitis.

The purpose of this study is to better understand liver detoxification in individuals living with this condition. The study is conducted entirely remotely, allowing participants to take part from home while supporting important liver research.

Quick Facts

Virtual

All study visits are conducted remotely, with virtual visits and in-home nursing support for sample collection.

For Adults

Adults age 18 years and older may be eligible to participate.

Condition

Diagnosed with Primary Sclerosing Cholangitis

Time Commitment

12-week study with a total of 9 virtual study visits

Who Can Participate?

Are 18 years of age or older
Have been diagnosed with Primary Sclerosing Cholangitis
Have elevated alkaline phosphatase (ALP) levels
Do not have certain medical conditions that would prevent participation

What to Expect

Nine total study visits conducted virtually

Seven visits supported by in-home nursing through Wren Health Care

Collection of blood, stool, and urine samples during home visits

Participation over a 12-week study period

No in-person clinic visits required

FAQ

We’ve pulled together some basics to help you

Who is conducting this study?

This study is conducted by researchers at Brigham and Women’s Hospital.

Where does participation take place?

All participation takes place remotely. Study visits are virtual, and in-home nurses collect required samples.

How long does the study last?

The study lasts 12 weeks and includes a total of 9 virtual visits.

What happens after I apply?

After completing a brief screening questionnaire, the study team will review your information and contact you if you may be eligible.

Join a Research Study for Adults With Primary Sclerosing Cholangitis